L Turecký

521 total citations
36 papers, 423 citations indexed

About

L Turecký is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, L Turecký has authored 36 papers receiving a total of 423 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 8 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Molecular Biology. Recurrent topics in L Turecký's work include Liver Disease Diagnosis and Treatment (11 papers), Diet, Metabolism, and Disease (5 papers) and Metabolism and Genetic Disorders (4 papers). L Turecký is often cited by papers focused on Liver Disease Diagnosis and Treatment (11 papers), Diet, Metabolism, and Disease (5 papers) and Metabolism and Genetic Disorders (4 papers). L Turecký collaborates with scholars based in Slovakia and Czechia. L Turecký's co-authors include Viera Kupčová, Peter Kalina, T Ravíngerová, Iveta Waczulı́ková, J Čársky, Katarı́na Volkovová, A Ziegelhöffer, A Dzurba, Albert Breier and J Styk and has published in prestigious journals such as Journal of Neurochemistry, International Journal of Environmental Research and Public Health and Current Medicinal Chemistry.

In The Last Decade

L Turecký

35 papers receiving 408 citations

Peers

L Turecký

EPIDE

PFM

EDM

ONCOL

Motoyuki Yoshida Japan

Eva Doleželová Czechia

Moti Rosenstock Israel

Xiaobin Mei China

Nora Anderson United States

Yasuhiro Sato Japan

Jing Hao China

T Krechler Czechia

Midhun C. Korrapati United States

Lijun Zhao China

Motoyuki Yoshida Japan

L Turecký

92 ×0.8

74 ×0.6

EPIDE

34 ×0.6

PFM

38 ×0.7

EDM

33 ×0.6

ONCOL

Citations per year, relative to L Turecký L Turecký (= 1×) peers Motoyuki Yoshida

Countries citing papers authored by L Turecký

Since Specialization

Citations

This map shows the geographic impact of L Turecký's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Turecký with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Turecký more than expected).

Fields of papers citing papers by L Turecký

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L Turecký. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Turecký. The network helps show where L Turecký may publish in the future.

Co-authorship network of co-authors of L Turecký

This figure shows the co-authorship network connecting the top 25 collaborators of L Turecký. A scholar is included among the top collaborators of L Turecký based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L Turecký. L Turecký is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Turecký, L, et al.. (2021). Serum butyrylcholinesterase activities in patients with non-alcoholic fatty liver disease. Comparison with liver proteosynthetic function and liver fibrosis. Bratislavské lekárske listy/Bratislava medical journal. 122(10). 689–694. 9 indexed citations

Murín, Ján, et al.. (2021). Central systolic blood pressure (cSBP) to brachial systolic blood pressure (brachSBP) ratio reproducibility during antihypertensive therapy. Bratislavské lekárske listy/Bratislava medical journal. 122(10). 695–699. 1 indexed citations

Turecký, L, et al.. (2021). Serum butyrylcholinesterase/HDL-cholesterol ratio and atherogenic index of plasma in patients with fatty liver disease. Vnitřní lékařství. 67(2). e04–e08. 11 indexed citations

Kupčová, Viera, et al.. (2018). Paraoxonase activity in sera of patients with non-alcoholic fatty liver disease. Bratislavské lekárske listy/Bratislava medical journal. 118(12). 719–720. 7 indexed citations

Turecký, L, et al.. (2018). Therapeutic effects of N-acetyl-L-cysteine on liver damage induced by long-term CCl4 administration. General Physiology and Biophysics. 37(1). 23–31. 19 indexed citations

Jerigová, Monika, et al.. (2018). Rat liver intoxication with CCl4: biochemistry, histology, and mass spectrometry. General Physiology and Biophysics. 37(5). 527–535. 8 indexed citations

Kupčová, Viera, et al.. (2017). Alpha-2-macroglobulin and hyaluronic acid as fibromarkers in patients with chronic hepatitis C. Bratislavské lekárske listy/Bratislava medical journal. 118(11). 658–661. 2 indexed citations

Líška, Branislav, et al.. (2016). Changes in levels of oxidative stress markers and some neuronal enzyme activities in cerebrospinal fluid of multiple sclerosis patients.. PubMed. 37(2). 102–6. 8 indexed citations

Kupčová, Viera, et al.. (2012). The Role of Oxidative Stress in Anti-tumor Necrosis Factor Antibody Treatment in Crohn´s Disease. Current Medicinal Chemistry. 19(30). 5226–5231. 7 indexed citations

10.

Kapalla, Marko, et al.. (2010). An overview of the healthcare system in the Slovak Republic. The EPMA Journal. 1(4). 549–561. 6 indexed citations

11.

Kupčová, Viera, et al.. (2008). Plasma copper and ceruloplasmin in patients with alcoholic liver steatosis.. PubMed. 109(10). 431–3. 14 indexed citations

12.

Turecký, L, et al.. (2005). Serum cholinesterase activity and proteosynthetic function of liver in patients with diabetes mellitus.. PubMed. 106(8-9). 266–9. 16 indexed citations

13.

Kupčová, Viera, et al.. (2003). Changes in acute phase proteins after anti-tumor necrosis factor antibody (infliximab) treatment in patients with Crohn´s disease.. Physiological Research. 52(1). 89–93. 16 indexed citations

14.

Kupčová, Viera, et al.. (2003). Different patterns of serum interleukin 10 response to treatment with anti-tumor necrosis factor α antibody (infliximab) in Crohn´s disease.. Physiological Research. 95–100. 4 indexed citations

15.

Kupčová, Viera, et al.. (2003). Different patterns of serum interleukin 10 response to treatment with anti-tumor necrosis factor alpha antibody (infliximab) in Crohn's disease.. PubMed. 52(1). 95–100. 6 indexed citations

16.

Ziegelhöffer, A, T Ravíngerová, J Styk, et al.. (1997). Mechanisms that may be involved in calcium tolerance of the diabetic heart. PubMed. 176(1-2). 191–198. 43 indexed citations

17.

Turecký, L, et al.. (1996). [Plasma proteins in patients with liver steatosis and the effect of treatment of essential phospholipids].. PubMed. 97(10). 625–8. 1 indexed citations

18.

Turecký, L, et al.. (1994). Cetaben is an exceptional type of peroxisome proliferator. International Journal of Biochemistry. 26(5). 679–696. 9 indexed citations

19.

Turecký, L, et al.. (1987). [Therapeutic effect of silymarin in patients with liver cirrhosis].. PubMed. 126(45). 1406–9. 2 indexed citations

20.

Turecký, L, et al.. (1984). Serum ceruloplasmin and copper levels in patients with primary brain tumors. Journal of Molecular Medicine. 62(4). 187–189. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact